1. Home
  2. PRK vs GPCR Comparison

PRK vs GPCR Comparison

Compare PRK & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park National Corporation

PRK

Park National Corporation

N/A

Current Price

$188.30

Market Cap

3.6B

Sector

Finance

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

N/A

Current Price

$41.82

Market Cap

3.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PRK
GPCR
Founded
1908
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.8B
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
PRK
GPCR
Price
$188.30
$41.82
Analyst Decision
Hold
Strong Buy
Analyst Count
3
12
Target Price
$184.00
$103.17
AVG Volume (30 Days)
71.3K
701.3K
Earning Date
04-24-2026
05-08-2026
Dividend Yield
2.61%
N/A
EPS Growth
19.21
N/A
EPS
5.64
N/A
Revenue
$664,421,000.00
N/A
Revenue This Year
$24.26
N/A
Revenue Next Year
$3.63
N/A
P/E Ratio
$33.78
N/A
Revenue Growth
2.92
N/A
52 Week Low
$149.06
$20.04
52 Week High
$215.00
$94.90

Technical Indicators

Market Signals
Indicator
PRK
GPCR
Relative Strength Index (RSI) 33.33 32.70
Support Level $181.01 $36.11
Resistance Level $188.04 $56.63
Average True Range (ATR) 4.15 2.64
MACD -1.73 -0.94
Stochastic Oscillator 3.45 11.23

Price Performance

Historical Comparison
PRK
GPCR

About PRK Park National Corporation

Park National Corp is a diversified financial services company based in Newark, Ohio, consisting of 11 community banking divisions with more than 100 offices in Ohio and Kentucky. The company provides the following principal services: the acceptance of deposits for demand, savings and time accounts; commercial, industrial, consumer and real estate lending, including installment loans, credit cards (which are largely offered through a third party), home equity lines of credit and commercial leasing; trust and wealth management services; cash management; safe deposit operations; electronic funds transfers; and a variety of additional banking-related services.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: